ABIOMED's net income for 9 months on a GAAP basis for fiscal year 2021 was $168.669 million, a decrease of 1.5% compared to $171.211 million in the previous year. Revenue decreased 4.4% to $606.277 million from $634.225 million a year earlier.
ABIOMED's net income for 9 months on a GAAP basis for fiscal year 2021 was $168.669 million, a decrease of 1.5% compared to $171.211 million in the previous year. Revenue decreased 4.4% to $606.277 million from $634.225 million a year earlier. 
investors.abiomed.com
English (US) 